Literature DB >> 11961301

Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype.

Young Sik Kim1, Yoon-Ok Ahn, Hyo Suk Lee.   

Abstract

To investigate risk factors for HCV infection according to the genotype, we studied 178 patients positive for HCV-PCR and 226 controls that were negative for the anti-HCV antibody. One hundred and twenty five controls (community control) were recruited from spouses of HCV-PCR-positive patients and the other 101 from hospital visitors (hospital control). HCV genotyping was performed by PCR, and epidemiological data were obtained from all participants. The distribution of HCV genotypes was as follows -- 1a (0.6%), 1b (39.9%), 2a (38.2%), 2b (0%), 3 (1.1%), and unclassified (20.2%). By multivariate analysis, blood transfusion (OR 2.90) and endoscopy (OR 2.80) were found to be risk factors for HCV genotype 1b versus the community control. Similarly, blood transfusion (OR 3.17) was found to be risk factors for HCV genotype 1b versus the hospital control. Blood transfusion (OR 2.75) and endoscopy (OR 3.57) were risk factors for HCV genotype 2a versus the community control, and blood transfusion (OR 4.55) and endoscopy (OR 2.16) were those versus the hospital control. Our results suggest that the risk factors for HCV infection are similar among the different genotypes. Blood transfusion and endoscopy were found to be associated with HCV infection.

Entities:  

Mesh:

Year:  2002        PMID: 11961301      PMCID: PMC3054844          DOI: 10.3346/jkms.2002.17.2.187

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  10 in total

Review 1.  Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy.

Authors:  Douglas B Nelson; Lawrence F Muscarella
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Intrafamilial transmission of hepatitis C virus infection.

Authors:  Eliseo Minola; Vincenzo Baldo; Tatjana Baldovin; Renzo Trivello; Annarosa Floreani
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 3.  Tattooing and risk of hepatitis B: a systematic review and meta-analysis.

Authors:  Siavash Jafari; Jane A Buxton; Kourosh Afshar; Ray Copes; Souzan Baharlou
Journal:  Can J Public Health       Date:  2012 May-Jun

4.  Behavioral and healthcare-associated risk factors for chronic hepatitis C virus infection in Korea.

Authors:  Jong Yeop Kim; Juhee Cho; Sung Ho Hwang; Ho Kil; Si Hyun Bae; Young Seok Kim; Han Chu Lee; Sook-Hyang Jeong
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

Review 5.  Current status of and strategies for hepatitis C control in South Korea.

Authors:  Beom Kyung Kim; Eun Sun Jang; Jeong Han Kim; Soo Young Park; Song Vogue Ahn; Hyung Joon Kim; Do Young Kim
Journal:  Clin Mol Hepatol       Date:  2017-09-19

6.  A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.

Authors:  Byung Chul You; Young Seok Kim; Hun il Kim; Se Hun Kim; Seung Sik Park; Yu Ri Seo; Sang Gyune Kim; Se Whan Lee; Hong Soo Kim; Soung Won Jeong; Jae Young Jang; Boo Sung Kim
Journal:  Clin Mol Hepatol       Date:  2012-09-25

7.  Prevalence of hepatitis C virus infections and distribution of hepatitis C virus genotypes among Korean blood donors.

Authors:  Deok Ja Oh; Yoon Mee Park; Young Ik Seo; Jae Sook Lee; Ja Young Lee
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

8.  Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation.

Authors:  Hyeyoung Kim; Kwang-Woong Lee; Nam-Joon Yi; Hae Won Lee; YoungRok Choi; Suk-Won Suh; Jaehong Jeong; Kyung-Suk Suh
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153

9.  Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study.

Authors:  Young Min Kim; Suk Bae Kim; Il Han Song; Sae Hwan Lee; Hong Soo Kim; Tae Hee Lee; Young Woo Kang; Seok Hyun Kim; Byung Seok Lee; Hee Bok Chae; Myeong Jun Song; Ji Woong Jang; Soon Young Ko; Jae Dong Lee
Journal:  Clin Mol Hepatol       Date:  2018-06-04

10.  Assessment of hepatitis C risk factors in center of Iran: A case-control study.

Authors:  Faramarz Shahriari-Fard; Sayed Moayed Alavian; Ziba Farajzadegan; Ali Rabiei; Behrooz Ataei; Mehdi Ataie
Journal:  J Res Med Sci       Date:  2018-10-26       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.